Therapeutic or Preventive Procedure – Page 74

Extended FDA Review Timeline for Ascendis’ Hormone Therapy

12 months ago talkbio0Tagged 3 months, Ascendis Pharma, Extension, Hormone Therapy, month, Review [Publication Type], United States Food and Drug Administration

Ascendis Pharma, hormone therapy, FDA review, delay, 3 months extension.

AbbVie and Gilgamesh Pharmaceuticals Join Forces in a $2 Billion Psychedelic Drug Development Partnership

12 months ago talkbio0Tagged AbbVie, Drug Development, Gilgamesh, Hallucinogens, Mental disorders, mental health, Neuroscience discipline, next-generation

AbbVie, Gilgamesh Pharmaceuticals, psychiatric disorders, psychedelic drugs, drug development, mental health, next-generation treatments, neuroscience, pharmaceutical collaboration, $2 billion deal.

Maze Therapeutics Secures New Partnership for Pompe Drug Development After Sanofi Deal Collapse

12 months ago talkbio0Tagged amsacrine/azacitidine/etoposide, Deal Collapse, Drug Development, Hereditary Diseases, Partnership, Pompe drug, sanofi

Maze Therapeutics, Pompe drug, partnership, Sanofi deal collapse, drug development, genetic diseases

Revolutionizing Healthcare: Streamlining Cell and Gene Therapy Manufacturing (Part 1)

12 months ago talkbio0Tagged Biotechnology, Cell Therapy, Cost Effectiveness, gene therapy, healthcare innovation, Manufacture, Precision Medicine, production, regulatory, scalability

Cell therapy, gene therapy, manufacturing, biotechnology, healthcare innovation, personalized medicine, production challenges, regulatory compliance, scalability, cost-effectiveness.

Revolutionizing Medicine: The Evolution and Future of Cell and Gene Therapy Manufacturing

12 months ago talkbio0Tagged Automation, biomanufacturing, CAR-T, Cell Therapy, gene therapy, Manufacture, Precision Medicine, regulatory, scale-up, Stem Cell Therapy, Viral Vector

Cell therapy manufacturing, gene therapy manufacturing, biomanufacturing, advanced therapies, CAR-T cell therapy, stem cell therapy, viral vectors, bioreactors, automation, scale-up, regulatory compliance, personalized medicine.

Revolutionary Gene Therapy Advancements: Early Trial Results from Leading Biotech Companies

12 months ago talkbio0Tagged ASGCT24, Clinical Trials, Creyon, Freeline, gene therapy, Hemophilia A, Hereditary Diseases, Liver diseases, Parkinson 's disease, Rocket

ASGCT24, gene therapy, early trial results, Freeline, Rocket, Creyon, biotech companies, genetic diseases, hemophilia, liver diseases, Parkinson’s disease.

Novo Nordisk and Metaphore Pharmaceuticals Join Forces in a $600 Million Partnership to Pioneer Innovative Obesity Treatments

12 months ago talkbio0Tagged Metabolic Diseases, next-generation, Nordisk, Obesity, Partnership, pharmaceutical collaboration, weight loss medications

Novo Nordisk, Metaphore Pharmaceuticals, obesity drugs, next-generation treatments, $600 million deal, partnership, pharmaceutical collaboration, weight loss medications, metabolic disorders.